Phase III trial shows gene therapy skin grafts help heal chronic wounds in blistering skin disease

Skin grafts genetically engineered from a patient’s own cells can heal persistent wounds in people with an extremely painful dermatologic disease, a Stanford Medicine-led clinical trial has shown. The grafts treat severe dystrophic epidermolysis bullosa, or EB, a genetic condition in which the skin is so fragile the slightest touch can cause blistering and wounds, eventually leading to large, open lesions that never heal and are immensely painful.
Read More

New study identifies cheek skin biomarkers in infancy that predict atopic dermatitis before symptoms appear

A new study conducted by researchers at National Jewish Health has found that early changes in the cheek skin barrier may predict the onset of eczema, or atopic dermatitis (AD), well before any clinical symptoms appear. AD can be linked to food allergies, with early skin reactions potentially increasing the risk of developing asthma later in life.
Read More

BNT162b2 vaccine not only targets COVID-19 virus, but may also help reduce and control innate inflammation

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended primary target. In a study recently published in the Clinical Immunology journal, researchers found that the vaccine not only targeted the COVID-19 virus, it also unexpectedly helped to reduce and control innate inflammation of other bacterial and fungal pathogens not related to the vaccine target.
Read More
Top